Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Not yet recruiting 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Thoracic 8Gastrointestinal 6Breast 6Genitourinary 3NET 2Endocrine 2Tumor-Agnostic 1Sarcoma 1Other solid neoplasm 1Head & Neck 1CNS 1

Conditions

Prostatic Neoplasms 2Urinary Bladder Neoplasms 1Disease 1

Interventions

Docetaxel 390pembrolizumab 326Prednisone 285Gemcitabine 273enzalutamide 256Radiotherapy 251Nivolumab 248Magnetic Resonance Spectroscopy 247Cisplatin 209Abiraterone Acetate 198Radiosurgery 184Leuprolide 182Sunitinib 169Carboplatin 161bicalutamide 148Goserelin 145Androgen Antagonists 142Specimen Handling 138Ipilimumab 128Paclitaxel 125Cyclophosphamide 116acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 110Bevacizumab 109Everolimus 107apalutamide 99abiraterone 99cabozantinib 98atezolizumab 97Sorafenib 97Radiation 89

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Liquid Biopsy × Genitourinary × Clear all
NCT07257718 2025-12-02

FUTURE

IRCCS San Raffaele

Phase 2 Not yet recruiting
262 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT05245435 2023-03-20

Diagnostic and Prognostic Accuracy of FDHT-PET and Liquid Biopsies in Prostate Cancer

Medical University of Vienna

Phase NA Withdrawn
Genitourinary

Prostatic Neoplasms

NCT04079699 2019-09-06

Predicting Prostate Cancer in Elderly Men

Odense University Hospital

Phase NA Not yet recruiting
700 enrolled
Genitourinary

Disease, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡